| CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis P Mohapatra, O Shriwas, S Mohanty, A Ghosh, S Smita, SR Kaushik, ... JCI insight 6 (4), 2021 | 60 | 2021 |
| The impact of m6A RNA modification in therapy resistance of cancer: implication in chemotherapy, radiotherapy, and immunotherapy O Shriwas, P Mohapatra, S Mohanty, R Dash Frontiers in Oncology 10, 612337, 2021 | 58 | 2021 |
| RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway O Shriwas, R Arya, S Mohanty, P Mohapatra, S Kumar, R Rath, ... British Journal of Cancer 124 (12), 2004-2016, 2021 | 22 | 2021 |
| CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis S Mohanty, P Mohapatra, O Shriwas, SA Ansari, M Priyadarshini, ... Oncogene 41 (45), 4929-4940, 2022 | 11 | 2022 |
| CMTM6 attenuates cisplatin‐induced cell death in OSCC by regulating AKT/c‐Myc‐driven ribosome biogenesis P Mohapatra, S Mohanty, SA Ansari, O Shriwas, A Ghosh, R Rath, ... The FASEB Journal 36 (10), e22566, 2022 | 10 | 2022 |
| Three-dimensional tumor model and their implication in drug screening for tackling chemoresistance M Priyadarshini, S Mohanty, T Mahapatra, P Mohapatra, R Dash Biomaterials for 3D Tumor Modeling, 481-503, 2020 | 3 | 2020 |
| Correction: RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway O Shriwas, R Arya, S Mohanty, P Mohapatra, S Kumar, R Rath, ... British Journal of Cancer 124 (12), 2039, 2021 | 2 | 2021 |
| CMTM6 mediates cisplatin resistance in OSCC by regulating AKT/c-MYC driven ribosome biogenesis P Mohapatra, S Mohanty, SA Ansari, O Shriwas, A Ghosh, R Rath, ... bioRxiv, 2022.04. 08.487634, 2022 | | 2022 |
| Nanopore 16S rRNA sequencing reveals alterations in nasopharyngeal microbiome and enrichment of Mycobacterium and Mycoplasma in patients with COVID 19 P Prasad, A Parida, S Mahapatra, R Mishra, KC Murmu, S Aggarwal, ... | | 2021 |
| CMTM6 drives cisplatin resistance in OSCC by regulating AKT mediated Wnt signaling P Mohapatra, O Shriwas, S Mohanty, SR Kaushik, R Arya, R Rath, ... bioRxiv, 2020.03. 18.993774, 2020 | | 2020 |
| MINK1 modulates 5FU resistance in OSCC through AKT/MDM2 mediated regulation of p53. One sentence summary: Lestaurtinib reverses 5FU sensitivity in drug resistant OSCC. S Mohanty, P Mohapatra, O Shriwas, M Priyadarshini, SA Ansari, ... | | |
